by Kharrazian Institute | Jul 21, 2026 | Autoimmunity, Blog
Most practitioners ordering an ANA panel believe they are assessing for autoimmunity. They are not. They are checking one narrow immunological window while the actual mechanisms driving tissue destruction continue undetected. The clinical gap between standard...
by Kharrazian Institute | Jul 17, 2026 | Blog, Gastrointestinal Disorders
The recurrence rate for SIBO after standard antibiotic treatment approaches 99 percent. That number is not an indictment of the antibiotics — it is an indictment of stopping there. The Kharrazian Institute’s clinical training teaches practitioners to treat SIBO...
by Kharrazian Institute | Jul 14, 2026 | Blog, Gastrointestinal Disorders
Most practitioners ordering gut permeability testing are measuring the wrong thing for the wrong patient at the wrong time. A zonulin panel comes back elevated, the practitioner notes “leaky gut,” and the protocol begins — usually glutamine, probiotics,...
by Kharrazian Institute | Jul 10, 2026 | Blog, Essentials of Functional Medicine
Most autoimmune patients arrive at a functional medicine practice already on a suppressive medication, already exhausted, and already told their diet doesn’t matter. The research says otherwise. Dietary interventions, sleep quality, stress physiology, and toxic...
by Kharrazian Institute | Jul 7, 2026 | Blog, Essentials of Functional Medicine
Most autoimmune patients arrive at a functional medicine clinic carrying the same thing: a diagnosis, a suppressive medication, and a list of symptoms that medication isn’t touching. The practitioner who treats the diagnosis will get the same result the...
by Kharrazian Institute | Jul 7, 2026 | Blog
In 2002, researchers published the results of the Women’s Health Initiative, a massive clinical trial designed to investigate the effects of menopausal hormone therapy (MHT) on postmenopausal women. The study claimed that hormone replacement therapy significantly...
